Clinical Trials for Seaport Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Seaport Therapeutics

Clinical Trials (2)

NCT07161700
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
PHASE2Enrolling by invitation
360 participants
Started: Sep 2, 2025 · Completed: May 31, 2027
2 conditions2 sponsors10 locations
NCT07065240
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
PHASE2Recruiting
360 participants
Started: Jun 19, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors29 locations